The xenografted tumors with knocked-down RPL19 were significantly smaller than those in the control tumors, and siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancer [39,40,41]. This evidence concerns the gene RPL19 and Familial prostate cancer.